Background
ECM components and their function in OS
ECM protein | Expression in OS | Roles in OS | References | |
---|---|---|---|---|
Collagens | Collagen I | Increase | Invasion and metastasis | [26] |
Collagen III | Increase | Chemotherapy resistance | [27] | |
Collagen IV | Increase | Angiogenesis | [28] | |
Collagen V | Increase | Adhesion | [29] | |
Collagen XVIII | Decrease | Anti-angiogenesis | ||
Cell growth and Metastasis | [32] | |||
Fibronectin | Increase | Adhesion | ||
Chemotherapy resistance | [36] | |||
Metastasis | ||||
Invasion | [39] | |||
Laminins | Increase | Adhesion | [40] | |
Invasion | ||||
Proteoglycans | Biglycan | Increase | Cell growth | |
Decorin | Decrease | Migration | [45] | |
Cell growth | [46] | |||
Lumican | Increase | Cell growth | [47] | |
Adhesion | [48] | |||
Versican | Increase | Migration and invasion | [49] | |
HA | Increase | Proliferation and invasion | ||
Cell apoptosis | [53] | |||
Metastasis |
Collagens
Collagen I
Collagen III
Collagen IV
Collagen V
Collagen XVIII
Fibronectin
Laminins
Proteoglycans
SLRPs
Modular proteoglycans
Ha
Signaling pathways responsible for ECM remodeling in OS
MMPs
Heparanase
ECM components as prognostic biomarkers in OS
ECM components | Expression in OS | Prognostic value | References | |
---|---|---|---|---|
Collagens | CTHRC1 | High | Shorter survival time | [116] |
COL1A1 | High | Shorter survival time | [118] | |
Fibronectin | High | Metastasis, poor response to chemotherapy, and shorter survival time | ||
Proteoglycans | CD44 | High | Poor response to chemotherapy | [54] |
Metastasis, recurrence and shorter survival time |
ECM components as potential therapeutic targets in OS
Therapeutic target | Functions | References | |
---|---|---|---|
Collagens | COL3A1 | Methotrexate resistance, apoptosis | [27] |
Tumstatin | Cell proliferation, apoptosis | [124] | |
Endostatin | Metastases | [125] | |
Fibronectin | Fibronectin | Doxorubicin sensitivity | [36] |
Integrins | Cell proliferation, metastasis | [129] | |
Proteoglycans | Decorin | Cell invasion, metastasis | [130] |
CD44 | Doxorubicin sensitivity | [54] |